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INTRODUCTION 
 
Opiates are natural alkaloids derived from the poppy plant - Papaver 
somniferum – and co nsidered t he b est an algesic co mpounds. 
Endogenous compounds with opiate-like biological activities are also 
existing i n t he nervous s ystems a nd o ther o rgans, t ermed o pioid 
peptides. The occurrence of three major opioid receptor types  (µ, δ, 
κ) interacting with the natural and synthetic opioid ligands has been 
also proved. Clinically used opioid analgesics act predominantly on 
µ-opioid receptors. It has been demonstrated that drugs acting on δ-
opioid receptors also exhibit strong analgesic activities, but produce 
fewer side effects. Therefore a number of ongoing efforts are aimed 
to de velop δ agonist li gands a s c entrally a cting a nalgesics. An 
important discovery was the demonstration that δ-antagonist ligands 
can reduce the development of analgesic tolerance and severity of the 
precipitated withdrawal s yndrome in mice. T his observation le d to  
the s uggestion t hat opi oid c ompounds with complex µ-agonist/δ-
antagonist p rofile might b e a nalgesics with a  low p roclivity to  
produce tolerance and dependence. The discovery of the prototype δ 
opioid a ntagonists T IPP ( H-Tyr-Tic-Phe-Phe-OH) and TIP ( H-Tyr-
Tic-Phe-OH) in  1 992 was followed b y e xtensive s tructure-activity 
relationship studies, leading to the development of novel analogues 
with a pplications i n opi oid r esearch a nd ph armacology. The f irst 
known peptide from the TIPP peptide series with mixed µ-agonist/δ-
antagonist ch aracters was t he C -terminally a midated te trapeptide 
TIPP-NH2 (H-Tyr-Tic-Phe-Phe-NH2). Further s tructure-activity 
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studies revealed that the δ-antagonist vs µ-agonist behavior of TIP(P) 
derived compounds depended on very subtle structural differences in 
diverse locations o f t he molecule and suggested a δ-receptor model 
involving a  num ber of  di fferent i nactive r eceptor c onformations. 
Various substitutions were carried out in different sequences in these 
peptides such as the replacement of Phe3 with β-methylphenyalanine 
resulting in an extraordinary δ-selectivity. The effects of methylation 
of the β-carbon of the third side chain on the biological properties of 
a peptide depends on the side-chain configurations of the 
stereoisomers. More i nterestingly, saturation o f t he P he3
In the present thesis biochemical characterization of a series of novel 
TIPP related, structurally modified tetrapeptide ligands is described, 
reporting the results of extensive in vitro studies. Altogether 10 novel 
TIPP r elated co mpounds w ere investigated, with different 
substitutions such a s N-terminal r eplacement of t yrosine b y Dmt 
(2’,6’-dimethyltyrosine) at the first position, and β-methyl-aminoacid 
substitution a t t he t hird p osition. T wo o f th e n ovel te trapeptides 
(DYTPP) were s ubstituted w ith β-methylphenyalanine in place o f 
Phe
 aromatic 
ring in T IPP, a s achieved t hrough s ubstitution o f c yclohexylalanine 
(Cha), l ed t o a  c ompound ( H-Tyr-Tic-Cha-Phe-OH) [T ICP] with 
substantially increased δ-antagonist potency and higher δ-selectivity 
comparing with the parent TIPP peptide.  
3 beside the above mentioned one resulting in two diastereomeric 
compounds on e o f t hem the Dmt-Tic-(2S,3R)βMePhe-Phe being 
studied in  r adiolabelled f orm a s well. T he la tter e ight te trapeptides 
(DYTCP stereomers – Dmt-Tic-βMeCha-Phe-Phe) carry β-
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methylcyclohexyalanine substitution at the third position as well as 
four of the stereomers have amidated C-termini. Amidation of the C-
terminus is e xpected t o en hance µ-opioid r eceptor a ffinity of t he 
ligands as it was demonstrated in the case o f the DYTCP amidated 
compounds as well. The tritiated analogue was shown to label opioid 
δ-sites i n r at b rain a nd C HO c ell li ne stably e xpressing δ-opioid 
receptors. The nonlabeled tetrapeptides were tested with highly 
selective r adioligands [ 3H]DAMGO (µ) and [ 3H]Ile5,6-deltorphin-II 
(δ) in c ompetition b inding a ssays. T he novel a nalogues presented 
very interesting an d co mplex i ntrinsic e fficacies i n r at b rain 
membranes as  well as  i n d ifferent cel lular s ystems. The r esults 
obtained with t he r adiolabeled [3
 
H]Dmt-Tic-(2S,3R)βMePhe-Phe 
compound f ulfill th e m ain criteria f or a valuable r adioligand. 
Regarding the n onlabeled stereomeric compounds they might serve 
as valuable pharmacological and therapeutic agents as well as probes 
for µ- and δ-receptor coupling. 
AIMS OF THE STUDIES 
 
Recently a  new series o f highly p otent, δ-receptor-selective o pioid 
antagonist have b een d eveloped b ased o n N -terminal m essage 
domain o f t he e ndogenous e nkephalins ( Tyr1-Gly2-Gly3-Phe4-) a nd 
amphibian s kin derived de rmorphins a nd de ltorphins ( Tyr1-D-Xaa2-
Phe3-, where Xaa2 is Met or Ala). These new antagonist contain at 
least t hree aromatic r esidues; o ne of  t hem be ing 1, 2,3,4-
tetrahydroisoquinoline-3-carboxilic aci d ( Tic). The co mbination o f 
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2’,6’-dimethyltyrosine ( Dmt) an d Tic p roduced p eptides with 
enhanced δ-receptor p otency an d s electivity. Further m odifications 
of these peptides resulted in more complex compounds which beside 
the hi gh δ-antagonist p rofiles d isplayed µ-agonist/δ-antagonist 
characters as  well. The ai m o f the present st udy was t o t est 
biochemically a nd functionally several n ewly d eveloped TIPP 
derived peptide analogues acting mainly through δ-opioid receptors 
as well a s to  study t heir structure-activity r elationship. In th e first 
part the structurally novel [ 3
- To have a novel opioid radioligand with improved activity and 
specificity. 
H]Dmt-Tic-(2S,3R)βMePhe-Phe 
diastereomeric TIPP derived radiolabeled analogue was 
biochemically analysed. The main goals were: 
- To m easure its  o pioid a ctivity in kinetic, e quilibrium a nd 
competition binding studies. 
- To compare its opi oid binding properties with those o f other 
well-known compounds labeling opioid receptors. 
Furthermore t he novel T IPP d erived n onlabeled d iastereomeric 
tetrapeptide ligands were biochemically and functionally analysed: 
- To investigate their binding properties to the native receptors. 
- To examine the post-binding effects (G-protein activation) in 
the functional biochemical [35
- To elucidate their intrinsic characteristics in native as well as 
in different cellular systems. 
S]GTPγS binding assay. 
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EXPERIMENTAL PROCEDURE 
 
Structural modifications on the TIPP related peptides as well as the 
radiolabeling w ere performed in t he Biological R esearch C entre 
Opioid Receptor Research group, Isotope laboratory, led by Dr. Tóth 
Géza as  well a s in t he Department o f O rganic Chemistry, Free 
University of Brussels, Belgium. For the biochemical and functional 
characterization of the novel tetrapeptides, a series of in vitro 
experiments were performed. The assays were carried out in Wistar 
rat b rain membranes a nd C hinese hamster o vary cel l l ines s tably 
expressing m ouse δ- (δmCHO) o r hu man µ-opioid ( µh
- Radioligand binding assays (Stauration, Displacement binding) 
CHO) 
receptors. For the in vitro characterization and the structure-activity 
studies:  
- [35
 
S]GTPγS binding assays were performed. 
SUMMARY OF RESULTS 
 
Since it was demonstrated that the δ-receptor sites are involved in the 
process o r p henomenon o f morphine t olerance an d d ependence t he 
focus is on the development of potent antagonist ligands with high 
selectivity for the δ-receptors. Recently a new series of highly potent, 
δ-receptor selective opioid antagonist tetrapeptide ligands have been 
reported. T he prototype a ntagonist l igand f rom t hese new pe ptides 
was T IPP ( Tyr-Tic-Phe-Phe) w hich w as f ollowed by extensive 
structure-activity r elationship studies. The p resent work focused on 
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the b iochemical a nd functional a nalysis o f a series of newly 
developed peptides from the TIPP series. The novel analogues carry 
different structural and conformational changes as substitution of the 
first T yr b y 2 ’,6’-dymethyltyrosine ( Dmt), th e unnatural 1, 2,3,4-
tetrahydroisoquinoline-3-carboxylic acid (Tic2), β-methyl-amino acid 
substitution at the third place as well C-terminal modification. In this 
work we r eport t he c ombination of  D mt1 and β-Me-amino a cid3
1. Side ch ain methylation o f P he b y βMePhe
 
substitution on the TIPP template structure and analyse the receptor 
binding a nd G -protein a ctivating pr operties of  t he novel pe ptide 
analogues. The main findings are the following: 
3
2. Specific binding of [
 yielded 
diastereomeric pairs of analogues wherein Dmt-Tic-(2S,3R)βMePhe-
Phe analogue was a p otent δ-selective antagonist compound and the 
Dmt-Tic-(2R,3S)βMePhe-Phe had hi gher µ-receptor a ffinities a nd 
less δ-selectivity. 
3
3.  Kinetic experiments showed that the ligand-receptor 
association occurred rapidly according to pseudo-first order kinetics. 
Equilibrium saturation ex periments r evealed t hat a s ingle cl ass o f 
nanomolar affinity opioid-binding sites was labeled by this 
radioligand.   
H]Dmt-Tic-(2S,3R)βMePhe-Phe to rat 
brain membranes and to membrane fractions of CHO cell lines stably 
expressing δ-opioid r eceptors was of  high a ffinity, s aturable a nd 
stereoselective.  
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4. Heterologous competition a ssays with d ifferent o pioid 
compounds revealed that the rank order of  potency is: δ > µ> κ in 
displacing [3
5. Side chain methyl substitution by βMeCha
H]Dmt-Tic-(2S,3R)βMePhe-Phe specific binding. 
3
6. C-terminal amidation of the DYTCP stereoisomers s lightly 
increased their µ-receptor affinity and µ-agonist properties. 
 resulted in four 
diastereomeric D YTCP c ompounds di splaying g ood δ-receptor 
affinities a nd different s electivities in f unction of t heir 
diastereomerism.  
7. Combination of  D mt1 and βMePhe3
8. The βMeCha
 replacements i n t he 
DYTPP l igands r esulted i n potent a nd more c omplex a nalogues 
displaying s imultaneously δ-antagonist/agonist a s well a s µ-
agonist/antagonist profiles in cell membrane preparations. 
3 substitution together with the Dmt1
In co nclusion t he n ovel t etrapeptide an alogues car rying 
different structural modification by their complex intrinsic properties 
may serve as valuable compounds in the biochemical and 
pharmacological research of the opioid system. Furthermore by their 
increased hydrophobicity imposed by dimethylation of Tyr as well as 
lipid solubility and low molecular weight might fulfill the suggested 
criteria r equired f or pa ssage through bl ood-brain b arrier t hus t hey 
might further o ffer new c ompounds for c linical studies. M oreover, 
 at the first 
position a nd C -terminal car boxamide group r esulted i n D YTCP 
stereoisomeric l igands with weak i nverse a gonist a ctivities in  r at 
brain an d cel l m embranes as  well as  mixed µ-agonist/δ-antagonist 
properties in cell membrane preparations in vitro.  
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analogues from the TIPP family by their structural resemblance with 
endomorphins ( Endomorpin 1:  Tyr-Pro-Trp-Phe-NH2 and 
endomorphin 2: Tyr-Pro-Phe-Phe-NH2
 
) might also r epresent a n 
interesting series for molecular modeling and searching for 
pharmacophore elements ‘since a single small structural modification 
can d rastically c hange the l igands’ intrinsic properties a nd 
characteristics.  
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